Cargando…
Effect of increased water intake on plasma copeptin in patients with chronic kidney disease: results from a pilot randomised controlled trial
OBJECTIVES: Increased water intake may have a beneficial effect on the kidney through suppression of plasma vasopressin. We examined the effect of increased water intake on plasma copeptin (a marker of vasopressin) over 6 weeks in patients with chronic kidney disease. DESIGN: Secondary analysis of a...
Autores principales: | Sontrop, Jessica M, Huang, Shi-Han, Garg, Amit X, Moist, Louise, House, Andrew A, Gallo, Kerri, Clark, William F |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4663439/ https://www.ncbi.nlm.nih.gov/pubmed/26603245 http://dx.doi.org/10.1136/bmjopen-2015-008634 |
Ejemplares similares
-
The chronic kidney disease Water Intake Trial (WIT): results from the pilot randomised controlled trial
por: Clark, William F, et al.
Publicado: (2013) -
The Chronic Kidney Disease Water Intake Trial: Protocol of a Randomized Controlled Trial
por: Clark, William F., et al.
Publicado: (2017) -
Randomised controlled trial to determine the efficacy and safety of prescribed water intake to prevent kidney failure due to autosomal dominant polycystic kidney disease (PREVENT-ADPKD)
por: Wong, Annette T Y, et al.
Publicado: (2018) -
Randomised controlled trial of high versus ad libitum water intake in patients with autosomal dominant polycystic kidney disease: rationale and design of the DRINK feasibility trial
por: El-Damanawi, Ragada, et al.
Publicado: (2018) -
Coronary Artery Bypass Grafting Surgery Off- or On-pump Revascularisation Study (CORONARY): kidney substudy analytic protocol of an international randomised controlled trial
por: Garg, Amit X, et al.
Publicado: (2012)